Related references
Note: Only part of the references are listed.HYAL1 overexpression is correlated with the malignant behavior of human breast cancer
Jin-Xiang Tan et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
Timo K. Nykopp et al.
BMC CANCER (2010)
Hyaluronan and hyaluronidase in genitourinary tumors
Melanie et al.
Frontiers in Bioscience-Landmark (2008)
HYAL1 and HYAL2 Inhibit Tumour Growth In Vivo but Not In Vitro
Fuli Wang et al.
PLOS ONE (2008)
Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells
Yuejuan Li et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer
L Udabage et al.
EXPERIMENTAL CELL RESEARCH (2005)
HYAL1 hyaluronidase: A molecular determinant of bladder tumor growth and invasion
VB Lokeshwar et al.
CANCER RESEARCH (2005)
Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer
S Ekici et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors
EJ Franzmann et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Inhibition of hyaluronan degradation by dextran sulphate facilitates characterisation of hyaluronan synthesis: An in vitro and in vivo study
L Udabage et al.
GLYCOCONJUGATE JOURNAL (2003)
Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors
A Jacobson et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses
M Slevin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice
MA Simpson et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Hyaluronan and homeostasis: A balancing act
MI Tammi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hyaluronan-cell interactions in cancer and vascular disease
BP Toole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Signaling properties of hyaluronan receptors
EA Turley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hyal2 -: less active, but more versatile?
G Lepperdinger et al.
MATRIX BIOLOGY (2001)
The six hyaluronidase-like genes in the human and mouse genomes
AB Csoka et al.
MATRIX BIOLOGY (2001)
Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer
VB Lokeshwar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation
SK Rai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling
G Lin et al.
CANCER LETTERS (2001)
Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival
P Auvinen et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Urinary hyaluronic acid and hyaluronidase: Markers for bladder cancer detection and evaluation of grade
VB Lokeshwar et al.
JOURNAL OF UROLOGY (2000)
Share Paper
